Metoprolol tartrate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
348 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | 3 | 9 | 20 | 34 | 17 | 78 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | 6 | 7 | 19 | 13 | 44 |
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | 2 | 2 | 5 | 13 | 13 | 34 |
| Coronary artery disease | D003324 | — | I25.1 | 1 | 1 | 2 | 5 | 13 | 21 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | 2 | 2 | 8 | 1 | 13 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | 1 | 2 | 2 | 6 | 3 | 13 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 3 | 1 | 1 | 5 | 1 | 11 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | 1 | — | 1 | 6 | 3 | 11 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 2 | 5 | 3 | 1 | 11 |
| Cardiomyopathies | D009202 | EFO_0000318 | I42 | — | 3 | 3 | 5 | 1 | 11 |
Show 86 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | 1 | 1 | — | 10 | 11 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 1 | 2 | — | 1 | 4 |
| Chronic renal insufficiency | D051436 | — | N18 | 1 | 2 | 1 | — | 1 | 4 |
| Burns | D002056 | — | T30.0 | — | 4 | 4 | — | — | 4 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | 1 | — | 1 | 3 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 1 | 1 | — | 1 | 3 |
| Congenital heart defects | D006330 | — | Q24.9 | — | 1 | 1 | — | 2 | 3 |
| Renal insufficiency | D051437 | — | N19 | — | — | 1 | — | 1 | 2 |
| Fibrosis | D005355 | — | — | — | 1 | 1 | — | — | 2 |
| Peripheral arterial disease | D058729 | EFO_0004265 | — | 1 | — | 1 | — | — | 2 |
Show 29 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 20 | 1 | — | — | — | 21 |
| Tachycardia | D013610 | — | R00.0 | 1 | 2 | — | — | 4 | 7 |
| Atopic dermatitis | D003876 | EFO_0000274 | L20 | 4 | 1 | — | — | — | 5 |
| Eczema | D004485 | — | L30.9 | 2 | 1 | — | — | — | 3 |
| Dermatitis | D003872 | — | L30.9 | 2 | 1 | — | — | — | 3 |
| Cognitive dysfunction | D060825 | — | G31.84 | — | 2 | — | — | — | 2 |
| Neoplasms | D009369 | — | C80 | 2 | 1 | — | — | — | 2 |
| Postural orthostatic tachycardia syndrome | D054972 | — | G90.A | — | 1 | — | — | 1 | 2 |
| Aortic valve stenosis | D001024 | EFO_0000266 | — | — | 1 | — | — | 1 | 2 |
| Wounds and injuries | D014947 | — | T14.8 | — | 2 | — | — | — | 2 |
Show 15 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetics | D010599 | — | — | 2 | — | — | — | 1 | 3 |
| Drug interactions | D004347 | — | — | 2 | — | — | — | 1 | 3 |
| Covid-19 | D000086382 | — | U07.1 | 1 | — | — | — | 1 | 2 |
| Pure autonomic failure | D054970 | — | — | 1 | — | — | — | 1 | 2 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 2 | — | — | — | — | 2 |
| Fasting | D005215 | EFO_0002756 | — | 2 | — | — | — | — | 2 |
| Malaria | D008288 | EFO_0001068 | B54 | 1 | — | — | — | — | 1 |
| Hepatitis c | D006526 | — | B19.2 | 1 | — | — | — | — | 1 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | 1 | — | — | — | — | 1 |
| Crohn disease | D003424 | EFO_0000384 | K50 | 1 | — | — | — | — | 1 |
Show 6 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | — | 3 | 3 |
| Percutaneous coronary intervention | D062645 | — | — | — | — | — | — | 2 | 2 |
| Kidney transplantation | D016030 | — | — | — | — | — | — | 2 | 2 |
| Cerebral hemorrhage | D002543 | — | — | — | — | — | — | 2 | 2 |
| Chest pain | D002637 | — | R07.9 | — | — | — | — | 2 | 2 |
| Coronary occlusion | D054059 | — | I21 | — | — | — | — | 1 | 1 |
| Drug-eluting stents | D054855 | — | — | — | — | — | — | 1 | 1 |
| Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | — | — | 1 | 1 |
| Vomiting | D014839 | — | R11.1 | — | — | — | — | 1 | 1 |
| Nausea | D009325 | — | R11.0 | — | — | — | — | 1 | 1 |
Show 18 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
10,806 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use